VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F. Stojdl, John C. Bell, Anthony Power et al.|Cancer Cell|2003Cited by 850
Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKRN. B. Abraham, John C. Bell, David F. Stojdl et al.|Journal of Biological Chemistry|1999Cited by 230